Evaluation of the Relationship Between Vitamin D Deficiency and Subclinical Cardiac Dysfunction Using 2D/3D Strain Echocardiography in Healthy People

Aim. Vitamin D deficiency has a high prevalence in the population and is highly associated with cardiovascular diseases. The aim of this study was to evaluate subclinical left ventricular (LV) function using strain analysis in healthy individuals with vitamin D deficiency.

Material and methods. 113 healthy volunteers were enrolled in the study (age, 44.1±7 yrs, 34 male). All volunteers underwent two-dimensional (2D) and three-dimensional (3D) speckle tracking echocardiography after conventional echocardiographic evaluation. The subjects were divided into two groups according to their vitamin D concentrations. 61 subjects with vitamin D less than 20 ng / ml were included in the vitamin D deficiency group. The baseline clinical characteristics, laboratory measurements, echocardiographic data, including 2D and 3D global longitudinal strain (GLS) values, were compared between the groups.

Results. The 2D GLS values of the subjects with vitamin D deficiency were lower (mathematically less negative) than subjects with normal vitamin D (–16.1±3.4 vs –19.3±4.2, p<0.001). Similarly, the 3D GLS results were lower in subjects with vitamin D deficiency (–18.3±5.2 vs –24.1±6.9, p<0.001). A significant correlation was detected between the vitamin D concentrations and the 2D and 3D GLS measurements. (r=0.765 and r=0.628, respectively, p<0.001). Vitamin D was found to be an independent predictor of impaired 2D and 3D LV GLS (p=0.031, p=0.023, respectively).

Conclusion. Subclinical LV dysfunction in healthy individuals with vitamin D deficiency was demonstrated by 3D and 2D strain analysis. Due to potential negative effects of vitamin D deficiency on cardiac function, more attention should be paid to healthy individuals with vitamin D deficiency.

1. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93(9):1137–46. DOI: 10.1136/hrt.2003.025270

2. Krum H, Teerlink JR. Medical therapy for chronic heart failure. The Lancet. 2011;378(9792):713–21. DOI: 10.1016/S0140-6736(11)61038-6

3. Chen Y, Zhao C-T, Zhen Z, Wong A, Tse HF, Yiu KH. Association of myocardial dysfunction with vitamin D deficiency in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications. 2014;28(3):286–90. DOI: 10.1016/j.jdiacomp.2014.01.003

4. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Journal of the American College of Cardiology. 2003;41(1):105–12. DOI: 10.1016/s0735-1097(02)02624-4

5. Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myocardial Infarction is Inversely Associated with Plasma 25-Hydroxyvitamin D3 Levels: A Community-Based Study. International Journal of Epidemiology. 1990;19(3):559–63. DOI: 10.1093/ije/19.3.559

6. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G. Serum 25-Hydroxyvitamin D3 Concentrations and Prevalence of Cardiovascular Disease Among Type 2 Diabetic Patients. Diabetes Care. 2006;29(3):722–4. DOI: 10.2337/diacare.29.03.06.dc05-2148

7. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V et al. Bone Mass, Vitamin D Deficiency, and Hyperparathyroidism in Congestive Heart Failure. The American Journal of Medicine. 1997;103(3):197–207. DOI: 10.1016/S0002-9343(97)00142-3

8. Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP et al. Association of Vitamin D Deficiency with Heart Failure and Sudden Cardiac Death in a Large Cross-Sectional Study of Patients Referred for Coronary Angiography. The Journal of Clinical Endocrinology & Metabolism. 2008;93(10):3927–35. DOI: 10.1210/jc.2008-0784

9. Welles CC, Whooley MA, Karumanchi SA, Hod T, Thadhani R, Berg AH et al. Vitamin D Deficiency and Cardiovascular Events in Patients With Coronary Heart Disease: Data From the Heart and Soul Study. American Journal of Epidemiology. 2014;179(11):1279–87. DOI: 10.1093/aje/kwu059

10. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Archives of Internal Medicine. 2008;168(15):1629–37. DOI: 10.1001/archinte.168.15.1629

11. Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala N-B et al. Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas. 2010;65(3):225–36. DOI: 10.1016/j.maturitas.2009.12.013

12. Holick MF. Vitamin D deficiency. The New England Journal of Medicine. 2007;357(3):266–81. DOI: 10.1056/NEJMra070553

13. Sunbul M, Bozbay M, Mammadov C, Cincin A, Atas H, Ozsenel EB et al. Effect of vitamin D deficiency and supplementation on myocardial deformation parameters and epicardial fat thickness in patients free of cardiovascular risk. The International Journal of Cardiovascular Imaging. 2015;31(4):765–72. DOI: 10.1007/s10554-015-0622-1

14. Omidi F, Hosseinsabet A. Is the longitudinal deformation of the left ventricle affected by vitamin D deficiency in nondiabetics? A 2D speckle-tracking echocardiographic study. Echocardiography. 2019;36(1):67–73. DOI: 10.1111/echo.14205

15. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism. 2011;96(7):1911–30. DOI: 10.1210/jc.2011-0385

16. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2015;28(1):1-39. e14. DOI: 10.1016/j.echo.2014.10.003

17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. The American Journal of Cardiology. 1986;57(6):450–8. DOI: 10.1016/0002-9149(86)90771-X

18. Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M et al. Two-dimensional strain–a novel software for real-time quantitative echocardiographic assessment of myocardial function. Journal of the American Society of Echocardiography. 2004;17(10):1021–9. DOI: 10.1016/j.echo.2004.06.019

19. Gotsman I, Shauer A, Zwas DR, Hellman Y, Keren A, Lotan C et al. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. European Journal of Heart Failure. 2012;14(4):357–66. DOI: 10.1093/eurjhf/hfr175

20. Liu LCY, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK et al. Vitamin D status and outcomes in heart failure patients. European Journal of Heart Failure. 2011;13(6):619–25. DOI: 10.1093/eurjhf/hfr032

21. Boxer RS, Kenny AM, Cheruvu VK, Vest M, Fiutem JJ, Piña II. Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure. American Heart Journal. 2010;160(5):893–9. DOI: 10.1016/j.ahj.2010.08.004

22. Pourdjabbar A, Dwivedi G, Haddad H. The role of vitamin D in chronic heart failure. Current Opinion in Cardiology. 2013;28(2):216–22. DOI: 10.1097/HCO.0b013e32835bd480

23. Meredith AJ, McManus BM. Vitamin D in Heart Failure. Journal of Cardiac Failure. 2013;19(10):692–711. DOI: 10.1016/j.cardfail.2013.09.002

24. Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. Prevalence of Hypovitaminosis D in Cardiovascular Diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). The American Journal of Cardiology. 2008;102(11):1540–4. DOI: 10.1016/j.amjcard.2008.06.067

25. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K et al. Vitamin D Deficiency and Risk of Cardiovascular Disease. Circulation. 2008;117(4):503–11. DOI: 10.1161/CIRCULATIONAHA.107.706127

26. Li YC, Kong J, Wei M, Chen Z-F, Liu SQ, Cao L-P. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. The Journal of Clinical Investigation. 2002;110(2):229–38. DOI: 10.1172/JCI15219

27. Walters MR, Ilenchuk TT, Claycomb WC. 1,25-Dihydroxyvitamin D3 stimulates 45Ca2+ uptake by cultured adult rat ventricular cardiac muscle cells. The Journal of Biological Chemistry. 1987;262(6):2536–41. PMID: 3818607

28. Santillán GE, Vazquez G, Boland RL. Activation of aβ-adrenergicsensitive Signal Transduction Pathway by the Secosteroid Hormone 1,25-(OH)2-Vitamin D3 in Chick Heart. Journal of Molecular and Cellular Cardiology. 1999;31(5):1095–104. DOI: 10.1006/jmcc.1999.0942

29. Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, BerglerKlein J et al. Cardiac Abnormalities in Patients with Primary Hyperparathyroidism: Implications for Follow-Up. The Journal of Clinical Endocrinology & Metabolism. 1997;82(1):106–12. DOI: 10.1210/jcem.82.1.3666

30. Van Ballegooijen AJ, Visser M, Cotch MF, Arai AE, Garcia M, Harris TB et al. Serum Vitamin D and Parathyroid Hormone in Relation to Cardiac Structure and Function: The ICELAND-MI Substudy of AGES-Reykjavik. The Journal of Clinical Endocrinology & Metabolism. 2013;98(6):2544–52. DOI: 10.1210/jc.2012-4252

31. Khalili H, Talasaz AH, Salarifar M. Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clinical Research in Cardiology. 2012;101(5):321–7. DOI: 10.1007/s00392-011-0394-0

32. Wasse H, Cardarelli F, De Staercke C, Hooper C, Veledar E, Guessous I. 25-hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-sectional study of African American ESRD patients. BMC Nephrology. 2011;12(1):24. DOI: 10.1186/1471-2369-12-24

33. Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. The Journal of Steroid Biochemistry and Molecular Biology. 2007;103(3–5):416–9. DOI: 10.1016/j.jsbmb.2006.12.081

34. Santoro C, Arpino G, Esposito R, Lembo M, Paciolla I, Cardalesi C et al. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility. European Heart Journal - Cardiovascular Imaging. 2017;18(8):930–6. DOI: 10.1093/ehjci/jex033

35. Vitarelli A, Martino F, Capotosto L, Martino E, Colantoni C, Ashurov R et al. Early Myocardial Deformation Changes in Hypercholesterolemic and Obese Children and Adolescents: A 2D and 3D Speckle Tracking Echocardiography Study. Medicine. 2014;93(12):e71. DOI: 10.1097/MD.0000000000000071

36. Nagata Y, Takeuchi M, Wu VC-C, Izumo M, Suzuki K, Sato K et al. Prognostic Value of LV Deformation Parameters Using 2D and 3D Speckle-Tracking Echocardiography in Asymptomatic Patients With Severe Aortic Stenosis and Preserved LV Ejection Fraction. JACC: Cardiovascular Imaging. 2015;8(3):235–45. DOI: 10.1016/j.jcmg.2014.12.009

37. Muraru D, Niero A, Rodriguez-Zanella H, Cherata D, Badano L. Threedimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging. Cardiovascular Diagnosis and Therapy. 2018;8(1):101–17. DOI: 10.21037/cdt.2017.06.01

38. De Isla LP, Balcones DV, Fernández-Golfín C, Marcos-Alberca P, Almería C, Rodrigo JL et al. Three-Dimensional-Wall Motion Tracking: A New and Faster Tool for Myocardial Strain Assessment: Comparison With Two-Dimensional-Wall Motion Tracking. Journal of the American Society of Echocardiography. 2009;22(4):325–30. DOI: 10.1016/j.echo.2009.01.001

39. Ozer P, Emet S, Karaayvaz E, Elitok A, Bilge A, Adalet K et al. Silent myocardial dysfunction in vitamin D deficiency. Archives of Medical Science – Atherosclerotic Diseases. 2020;5(1):153–62. DOI: 10.5114/amsad.2020.97110

40. Akhavan-Khaleghi N, Hosseinsabet A, Mohseni-Badalabadi R. Effects of vitamin D deficiency on left atrial function as evaluated by 2D speckle-tracking echocardiography. Journal of Clinical Ultrasound. 2018;46(5):334–40. DOI: 10.1002/jcu.22548

41. Pishgahi M, Niroomand M, Bozorgmehr R, Ghane-Fard S, Mousavi F, Tabary M et al. Association between Serum Vitamin D Level and Echocardiographic Abnormalities in Patients with Thalassemia Major. Cardiovascular & Hematological Disorders-Drug Targets. 2020;20(3):214– 20. DOI: 10.2174/1871529X20666200701104931

42. Patange AR, Valentini RP, Gothe MP, Du W, Pettersen MD. Vitamin D Deficiency Is Associated With Increased Left Ventricular Mass and Diastolic Dysfunction in Children With Chronic Kidney Disease. Pediatric Cardiology. 2013;34(3):536–42. DOI: 10.1007/s00246-012-0489-z